XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.3
EQUITY METHOD INVESTMENTS (Tables)
 9 Months Ended
Sep. 30, 2023
Schedule of Equity Method Investments [Line Items]  
Equity Method Investments [Table Text Block]
The following summarizes the items comprising Equity Earnings, Impairment Charges, Tax Expense (Benefit), Discontinued Operations and Dividends related to the sale of our equity interest in Ilim:

In millionsEquity EarningsImpairment ChargesTax Expense (Benefit)Discontinued Operations, net of tax (a)Dividends
2022 First Quarter$93 $— $— $93 $204 
2022 Second Quarter95 — — 95 — 
2022 Third Quarter64 — — 64 — 
2022 Fourth Quarter44 533 — (489)— 
2023 First Quarter43 43 — — — 
2023 Second Quarter46 33 — 13 13 
2023 Third Quarter23 59 (9)(27)— 
Nine Months Ended September 30, 2022252 — — 252 204 
Nine Months Ended September 30, 2023112 135 (9)(14)13 
(a)    Discontinued operations, net of tax is Equity Earnings less Impairment Charges and Tax Expense (Benefit)

Summarized financial information for Ilim through the date of sale is presented in the following table:

Balance Sheet
In millionsSeptember 18, 2023December 31, 2022
Current assets$659 $766 
Noncurrent assets2,745 3,663 
Current liabilities1,362 1,275 
Noncurrent liabilities1,064 2,040 
Noncontrolling interests36 40 

Income Statement (a)
Three Months Ended
September 30,		Nine Months Ended
September 30,
In millions2023202220232022
Net sales$420 $834 $1,623 $2,356 
Gross profit176 391 706 1,234 
Income (loss) from continuing operations45 129 221 501 
Net income (loss)43 124 211 486